Grey cap tubes have abandoned the conventional potassium oxalate-NaF anticoagulation system and have creatively adopted the globally leading com-posite anticoagulation system. While having maintained the functions of inhibit glycometab-olism and prevent glucose degradation of conventional grey cap tubes, they have avoided the risk of extrinsic blood coagulation and hemolytic, so as to ensure the long-time stability of blood glucose specimen.